HRT Financial’s Invesco Bloomberg Analyst Rating Improvers ETF UPGD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-9,026
Closed -$667K 4915
2025
Q4
$667K Buy
9,026
+3,073
+52% +$229K ﹤0.01% 1955
2025
Q3
$445K Buy
+5,953
New +$437K ﹤0.01% 1951
2024
Q2
Sell
-4,592
Closed -$303K 3268
2024
Q1
$303K Buy
+4,592
New +$289K ﹤0.01% 1545
2020
Q4
Sell
-6,654
Closed -$264K 2576
2020
Q3
$264K Buy
+6,654
New +$267K 0.01% 1222

Other funds holding UPGD

HRT Financial's UPGD Position: Q1 2026 in Review

HRT Financial sold out of Invesco Bloomberg Analyst Rating Improvers ETF (UPGD) in Q1 2026, closing a stake of 9,026 shares — an estimated $667K sold.

HRT Financial first reported a position in UPGD in Q3 2020 and held it in 4 quarters. The position peaked at $667K in Q4 2025. 31 funds tracked by Wall St. Rank hold UPGD as of Q1 2026.

  • HRT Financial reported no remaining Invesco Bloomberg Analyst Rating Improvers ETF position as of Q1 2026 after selling out during the quarter.
  • HRT Financial sold 9,026 Invesco Bloomberg Analyst Rating Improvers ETF shares in Q1 2026, an estimated $667K.
  • HRT Financial first reported a position in Invesco Bloomberg Analyst Rating Improvers ETF in Q3 2020 and held it in 4 quarters.
  • HRT Financial's Invesco Bloomberg Analyst Rating Improvers ETF position peaked at $667K in Q4 2025.
  • 31 funds tracked by Wall St. Rank held Invesco Bloomberg Analyst Rating Improvers ETF as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.